Cardiac biomarkers are strongly predict coronary bypass surgery

Levels of a biomarker for diagnosis of heart attacks are used almost universally higher among patients receiving coronary artery bypass graft (CABG) and, if it increases significantly the forecasts, with force, a team of researchers from Massachusetts General Hospital (MGH have been found) Heart Institute. The report assumes that during the measurement of cardiac troponin T (cTnT May) to help determine the prognosis of a patient, the recommendations of current consensus on the use of cTnT to diagnose post-CABG myocardial infarction (MI ) should probably be reconsidered. The paper is in the September 8th issue of traffic and was published online: "Although the postoperative levels of cTnT were strongly predictive of the risk of complications and mortality after CABG, we found that reducing the currently recommended points for the diagnosis of heart attack are much too low, "says James Januzzi, MD, director of the Montreal General Hospital Cardiac Intensive Care Unit, lead author of the study. "But the use of cTnT for predicting the risk of postoperative general is very promising."

Patients after bypass surgery, is stuck in the blood supply to the heart muscle by one or more coronary arteries, the risk for a number of postoperative complications, including heart attacks diverted. Current standards for diagnosis of myocardial infarction after surgery in mind that symptoms such as chest pain, ECG changes and the results of biomarker tests. However, since patients after cardiac operations inevitably experience chest pain, and results of the postoperative ECG are often unclear, physicians may rely heavily on biomarkers such as cTnT post CABG diagnose heart attacks.

A previous study determined the prognostic role of cTnT in cardiac surgery patients that extreme levels of the enzyme strongly predict the risk of complications and death within one year after the operation. However, this study focuses on a mix of post-cardiac surgery patients, and not also consider the guidelines for diagnosis in a consensus statement in 2007 by four organizations including the American Heart Association and American College of Cardiology outlined.

This study was specifically designed for the usefulness of cTnT in the diagnosis of heart attack and CABG followed by considerations related to the level of postoperative cTnT and advance and cTnT levels of postoperative complications in general. Measuring levels of cTnT were taken later from nearly 850 patients CABG immediately after the procedure and 6, 8, 18 and even 24 hours. These quantities were then analyzed based on several factors, the main disease of the patient, surgical and related short-term and long-term results.

The results showed that cTnT levels were raised in almost all patients after CABG, but only 2 percent actually met the criteria postoperative myocardial infarction. Factors that predict the cTnT elevation included the complexity of coronary artery blockages first, the number of transplants that have been marketed and the state immediate postoperative patient. During the almost universal level of cTnT is a less useful indicator of myocardial infarction, cTnT levels 10 times higher than the current consensus guidelines, powerful and independent risk of death and other postoperative complications predicted and added to the power prediction of risk-rating models as developed by the Society for Thoracic Surgery.

"The results imply that the diagnosis of the Regional Post-CABG myocardial infarction should be largely based on clinical evaluation and angiographic demonstration of post-operative closure of a bypass operation, which, fortunately, a situation in predicate rare, "said Januzzi, an associate professor of medicine at Harvard Medical School. "Reflecting on the other hand, diffuse myocardial excessive - as cTnT separate investigation - may be more common than previously thought and cTnT has appointed an excellent job of identifying those patients for complications during the postoperative period. This is a strong argument that troponin testing should be included in all positions at risk CABG, irrespective of their use for diagnosis of infarction. "